v3 Template
L

Liquidia Corporation

Healthcare / Biotechnology San Francisco, California ~480 employees
Founded
--
Employees (Est.)
~480
24 leaders known
Total Funding
$375.0M
Funding Rounds
5
Last Funding
2025-06-23

About Liquidia Corporation

Liquidia Corporation is dedicated to developing best-in-class therapies for rare cardiopulmonary diseases such as pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Their mission is to help patients breathe easier and live longer through innovative inhaled therapies.

Products & Services

L606:A product in the pipeline focused on cardiopulmonary disease treatment.
Inhaled Treprostinil:A therapy targeted at pulmonary hypertension conditions like PAH and PH-ILD.

Specialties

Pulmonary Hypertension Cardiopulmonary Diseases Inhaled Therapies PRINT Technology

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Debt
T: -
FT: Debt
A: 50000000
MR: -
FA: 50.0 million
FAN: 50000000
D: 2025-06-23
FD: 2025-06-23
1 investors
2 RT: Public Offering and Debt Financing
T: -
FT: Public Offering and Debt Financing
A: 100000000
MR: -
FA: 100 million
FAN: 100000000
D: 2024-09-11
FD: 2024-09-11
2 investors
3 RT: Private Placement and Debt Financing
T: -
FT: Private Placement and Debt Financing
A: 100000000
MR: -
FA: 100 million
FAN: 100000000
D: 2024-01-04
FD: 2024-01-04
2 investors
4 RT: Public Offering
T: -
FT: Public Offering
A: 25000000
MR: -
FA: approximately $25.0 million
FAN: 25000000
D: 2023-12-12
FD: 2023-12-12
2 investors
5 RT: Revenue Interest Financing
T: -
FT: Revenue Interest Financing
A: 100000000
MR: -
FA: up to $100 million
FAN: 100000000
D: 2023-01-09
FD: 2023-01-09
1 investors
Debt Latest
2025-06-23
$50.0M
1 investor (Pro only)
Public Offering and Debt Financing 2024-09-11
$100.0M
Private Placement and Debt Financing 2024-01-04
$100.0M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

R

Roger Jeffs

Chief Executive Officer

M

Michael Kaseta

Chief Operating Officer & Chief Financial Officer

R

Rajeev Saggar

Chief Medical Officer

S

Scott Moomaw

Chief Commercial Officer

J

Jason Adair

Chief Business Officer

R

Rusty Schundler

General Counsel

View 21 more team members with Pro

Unlock Full Team Directory

Recent News

Liquidia Corporation Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare / Biotechnology
Company Size
~480 employees (est.)
Locations
San Francisco, California
MORRISVILLE, N.C.
Morrisville, North Carolina +1 more

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro